ACP3
Basic information
Region (hg38): 3:132317369-132368302
Previous symbols: [ "ACPP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 1 | 2 |
Variants in ACP3
This is a list of pathogenic ClinVar variants found in the ACP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-132317466-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
3-132317481-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
3-132317527-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
3-132328263-T-C | Likely benign (Mar 29, 2018) | |||
3-132328294-A-G | not specified | Uncertain significance (Nov 30, 2022) | ||
3-132328301-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
3-132328319-T-C | not specified | Uncertain significance (Oct 11, 2024) | ||
3-132328324-G-C | not specified | Uncertain significance (Jan 24, 2023) | ||
3-132328360-C-G | not specified | Uncertain significance (Jan 02, 2024) | ||
3-132331678-A-G | not specified | Uncertain significance (Oct 02, 2023) | ||
3-132331684-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
3-132332213-G-A | not specified | Likely benign (Apr 09, 2024) | ||
3-132332219-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
3-132332220-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-132332238-T-C | not specified | Uncertain significance (Jan 27, 2022) | ||
3-132332270-G-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-132332272-T-C | Benign (May 25, 2018) | |||
3-132332297-C-A | not specified | Uncertain significance (Aug 04, 2024) | ||
3-132332307-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-132337468-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
3-132337474-A-G | not specified | Uncertain significance (Apr 12, 2022) | ||
3-132337486-C-T | not specified | Uncertain significance (May 08, 2024) | ||
3-132337495-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
3-132337518-A-G | Likely benign (Jun 06, 2018) | |||
3-132342627-G-A | not specified | Uncertain significance (Oct 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACP3 | protein_coding | protein_coding | ENST00000351273 | 11 | 50932 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.55e-16 | 0.00868 | 125374 | 3 | 370 | 125747 | 0.00148 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.168 | 221 | 228 | 0.969 | 0.0000115 | 2738 |
Missense in Polyphen | 87 | 84.962 | 1.024 | 997 | ||
Synonymous | -0.306 | 87 | 83.4 | 1.04 | 0.00000426 | 785 |
Loss of Function | 0.0111 | 24 | 24.1 | 0.998 | 0.00000122 | 282 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00173 | 0.00173 |
Ashkenazi Jewish | 0.0173 | 0.0169 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000912 | 0.000906 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.00125 | 0.00124 |
Other | 0.00181 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: A non-specific tyrosine phosphatase that dephosphorylates a diverse number of substrates under acidic conditions (pH 4-6) including alkyl, aryl, and acyl orthophosphate monoesters and phosphorylated proteins. Has lipid phosphatase activity and inactivates lysophosphatidic acid in seminal plasma.;
- Pathway
- Vitamin B2 (riboflavin) metabolism;Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- loftool
- 0.795
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.91
Haploinsufficiency Scores
- pHI
- 0.185
- hipred
- N
- hipred_score
- 0.440
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acpp
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; neoplasm; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- purine nucleobase metabolic process;thiamine metabolic process;nucleotide metabolic process;dephosphorylation;neutrophil degranulation;adenosine metabolic process;protein homotetramerization;regulation of sensory perception of pain;positive regulation of adenosine receptor signaling pathway
- Cellular component
- extracellular space;nucleus;lysosomal membrane;plasma membrane;vesicle membrane;integral component of membrane;filopodium;azurophil granule membrane;extracellular exosome
- Molecular function
- acid phosphatase activity;protein binding;5'-nucleotidase activity;phosphatase activity;thiamine phosphate phosphatase activity;identical protein binding;protein homodimerization activity;lysophosphatidic acid phosphatase activity